Orphan designation: Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-beta-D-galactopyranosyl) sulfane Treatment of ...
At the time of designation, idiopathic pulmonary fibrosis affected approximately 3.2 in 10,000 people in the European Union (EU). This was equivalent to a total of around 166,000 people*, and is below the ceiling for orphan designation, which is 5 people …